| Bioactivity | Nanterinone (mesylate) is an orally active and positive inotropic and balanced-type vasodilating agent, partially based on phosphodiesterase III inhibition with venodilating properties. Nanterinone (mesylate) is promising for research of cardiovascular diseases[1]. |
| CAS | 102791-74-2 |
| Formula | C16H19N3O4S |
| Molar Mass | 349.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Remme WJ, et al. Acute hemodynamic effects and preload-dependent cardiovascular profile of the partial phosphodiesterase inhibitor nanterinone in patients with mild to moderate heart failure. Cardiovasc Drugs Ther. 1996 May;10(2):137-44. |
Nanterinone mesylate
CAS: 102791-74-2 F: C16H19N3O4S W: 349.40
Nanterinone (mesylate) is an orally active and positive inotropic and balanced-type vasodilating agent, partially based
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.